{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T08:40:17Z","timestamp":1773218417197,"version":"3.50.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2,15]]},"DOI":"10.2146\/ajhp100700","type":"journal-article","created":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T16:41:29Z","timestamp":1328200889000},"page":"291-300","source":"Crossref","is-referenced-by-count":15,"title":["Strategies to preserve the use of statins in patients with previous muscular adverse effects"],"prefix":"10.1093","volume":"69","author":[{"given":"Kurt M.","family":"Reinhart","sequence":"first","affiliation":[{"name":"School of Pharmacy, Wingate University, Asheville, NC, and Charles George Veterans Affairs Medical Center, Asheville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Andrew","family":"Woods","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Wingate University, and Clinical Pharmacy Specialist, Internal Medicine, Carolinas Medical Center, Charlotte, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041606591424600_b1-0690291","first-page":"1383","article-title":"Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"The Scandinavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet."},{"key":"2019041606591424600_b2-0690291","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med."},{"key":"2019041606591424600_b3-0690291","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med."},{"key":"2019041606591424600_b4-0690291","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(98)10279-9","article-title":"Lifetime risk of developing coronary heart disease","volume":"353","author":"Lloyd-Jones","year":"1999","journal-title":"Lancet."},{"key":"2019041606591424600_b5-0690291","first-page":"437","article-title":"Discontinuation rates of cholesterol-lowering medications: implications for primary care","volume":"5","author":"Hiatt","year":"1999","journal-title":"Am J Manag Care."},{"key":"2019041606591424600_b6-0690291","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-150-12-200906160-00009","article-title":"Narrative review: statin-related myopathy","volume":"150","author":"Joy","year":"2009","journal-title":"Ann Intern Med."},{"key":"2019041606591424600_b7-0690291","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s11606-008-0636-7","article-title":"Prevalence of musculoskeletal pain and statin use","volume":"23","author":"Buettner","year":"2008","journal-title":"J Gen Intern Med."},{"key":"2019041606591424600_b8-0690291","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.amjmed.2003.10.033","article-title":"Current overview of statin-induced myopathy","volume":"116","author":"Rosenson","year":"2004","journal-title":"Am J Med."},{"key":"2019041606591424600_b9-0690291","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials."},{"key":"2019041606591424600_b10-0690291","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.amjcard.2007.09.096","article-title":"Effectiveness of ezetimibe alone or in combination with twice a week atorvastatin (10 mg) for statin intolerant high-risk patients","volume":"101","author":"Athyros","year":"2008","journal-title":"Am J Cardiol."},{"key":"2019041606591424600_b11-0690291","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1345\/aph.1K604","article-title":"Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance","volume":"42","author":"Backes","year":"2008","journal-title":"Ann Pharmacother."},{"key":"2019041606591424600_b12-0690291","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.amjcard.2008.02.061","article-title":"Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins","volume":"101","author":"Gadarla","year":"2008","journal-title":"Am J Cardiol."},{"key":"2019041606591424600_b13-0690291","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1559-4572.2009.00055.x","article-title":"Efficacy of combination drug pulse therapy in maintaining lipid levels in patients intolerant of daily statin use","volume":"11","author":"Reddy","year":"2009","journal-title":"J Clin Hypertens."},{"key":"2019041606591424600_b14-0690291","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.amjcard.2008.09.095","article-title":"Once-a-week rosuvastatin (2.5 to 20 mg) in patients with a previous statin intolerance","volume":"103","author":"Ruisinger","year":"2009","journal-title":"Am J Cardiol."},{"key":"2019041606591424600_b15-0690291","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.trsl.2008.11.002","article-title":"Low serum 25 (OH) vitamin D levels (<32 ng\/mL) are associated with reversible myositis-myalgia in statin-treated patients","volume":"153","author":"Ahmed","year":"2009","journal-title":"Transl Res."},{"key":"2019041606591424600_b16-0690291","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.amjcard.2006.12.063","article-title":"Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins","volume":"99","author":"Caso","year":"2007","journal-title":"Am J Cardiol."},{"key":"2019041606591424600_b17-0690291","first-page":"3a","article-title":"Coenzyme Q10 improves myopathic pain in statin treated patients","volume":"45","author":"Kelly","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"2019041606591424600_b18-0690291","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.amjcard.2007.06.030","article-title":"Effect of coenzyme Q10 supplementation on simvastatin-induced myalgia","volume":"100","author":"Young","year":"2007","journal-title":"Am J Cardiol."},{"key":"2019041606591424600_b19-0690291","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjcard.2009.10.045","article-title":"Lipid-lowering efficacy of red yeast rice in a population intolerant to statins","volume":"105","author":"Venero","year":"2010","journal-title":"Am J Cardiol."},{"key":"2019041606591424600_b20-0690291","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjcard.2009.08.672","article-title":"Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance","volume":"105","author":"Halbert","year":"2010","journal-title":"Am J Cardiol."},{"key":"2019041606591424600_b21-0690291","doi-asserted-by":"crossref","first-page":"830","DOI":"10.7326\/0003-4819-150-12-200906160-00006","article-title":"Red yeast rice for dyslipidemia in statin-intolerant patients","volume":"150","author":"Becker","year":"2009","journal-title":"Ann Intern Med."},{"key":"2019041606591424600_b22-0690291","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.amjcard.2007.09.099","article-title":"Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins","volume":"101","author":"Stein","year":"2008","journal-title":"Am J Cardiol."},{"key":"2019041606591424600_b23-0690291","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1001\/archinte.165.22.2671","article-title":"Outcomes in 45 patients with statin-associated myopathy","volume":"165","author":"Hansen","year":"2005","journal-title":"Arch Intern Med."},{"key":"2019041606591424600_b24-0690291","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.clinthera.2006.06.004","article-title":"Rosuvastatin 5 and 10 mg\/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with non-statin lipid-lowering therapies","volume":"28","author":"Glueck","year":"2006","journal-title":"Clin Ther."},{"key":"2019041606591424600_b25-0690291","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.4065\/80.9.1163","article-title":"Conversion to atorvastatin in patients intolerant or refractory to simvastatin therapy: the CAPISH study","volume":"80","author":"Krasuski","year":"2005","journal-title":"Mayo Clin Proc."},{"key":"2019041606591424600_b26-0690291","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4065\/78.12.1463","article-title":"Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain","volume":"78","author":"Plotnikoff","year":"2003","journal-title":"Mayo Clin Proc."},{"key":"2019041606591424600_b27-0690291","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/clpt.2008.165","article-title":"Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence","volume":"85","author":"Schwartz","year":"2009","journal-title":"Clin Pharmacol Ther."},{"key":"2019041606591424600_b28-0690291","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med."},{"key":"2019041606591424600_b29-0690291","unstructured":"National Library of Medicine. Vitamin D replacement: the effect on statin-related myalgias. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01022398 (accessed 2010 Dec 6)."},{"key":"2019041606591424600_b30-0690291","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0002-9149(97)89180-1","article-title":"The effect of simvastatin treatment on the natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle","volume":"77","author":"Kaaksonene","year":"1996","journal-title":"Am J Cardiol."},{"key":"2019041606591424600_b31-0690291","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","article-title":"High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial","volume":"78","author":"Paiva","year":"2005","journal-title":"Clin Pharmacol Ther."},{"key":"2019041606591424600_b32-0690291","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archneur.62.11.1709","article-title":"Muscle coenzyme Q10 level in statin-related myopathy","volume":"62","author":"Lamperti","year":"2005","journal-title":"Arch Neurol."},{"key":"2019041606591424600_b33-0690291","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2007.02.049","article-title":"The role of coenzyme Q10 in statin-associated myopathy. A systematic review","volume":"49","author":"Marcoff","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"2019041606591424600_b34-0690291","first-page":"248","article-title":"Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature","volume":"6","author":"Patrick","year":"2001","journal-title":"Altern Med Rev."},{"key":"2019041606591424600_b35-0690291"},{"key":"2019041606591424600_b36-0690291","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/archinternmed.2010.382","article-title":"Marked variability of monacolin levels in commercial red yeast rice products","volume":"170","author":"Gordon","year":"2010","journal-title":"Arch Intern Med."},{"key":"2019041606591424600_b37-0690291","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-152-2-201001190-00023","article-title":"Red yeast rice for dyslipidemia in statin-intolerant patients","volume":"152","author":"Kolpakchi","year":"2010","journal-title":"Ann Intern Med."},{"key":"2019041606591424600_b38-0690291","unstructured":"National Library of Medicine. Red yeast rice and phytosterols in statin intolerance. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00897975 (accessed 2010 Dec 6)."},{"key":"2019041606591424600_b39-0690291","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00002018-200225090-00004","article-title":"Effects of HMG-CoA reductase inhibitors on skeletal muscle. Are all statins the same?","volume":"25","author":"Evans","year":"2002","journal-title":"Drug Saf."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/69\/4\/291\/28455587\/ajhp0291.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T11:00:01Z","timestamp":1555412401000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/69\/4\/291\/5112122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,15]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,2,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp100700","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,2,15]]},"published":{"date-parts":[[2012,2,15]]}}}